OA
ALXN

OFI Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

OFI Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$190K Buy
1,212
+53
+5% +$9.67K 0.01% 1228
2015
Q2 		$210K Buy
1,159
+109
+10% +$18.8K 0.01% 1226
2015
Q1 		$182K Sell
1,050
-111
-10% -$20.1K 0.01% 1287
2014
Q4 		$215K Buy
1,161
+232
+25% +$43K 0.01% 1171
2014
Q3 		$154K Buy
929
+74
+9% +$12.2K 0.01% 1284
2014
Q2 		$134K Buy
855
+227
+36% +$35.8K 0.01% 1349
2014
Q1 		$96K Sell
628
-156
-20% -$24.8K 0.01% 1438
2013
Q4 		$104K Buy
784
+58
+8% +$6.96K 0.01% 1398
2013
Q3 		$84K Sell
726
-116
-14% -$12.7K 0.01% 1400
2013
Q2 		$78K Buy
+842
New +$81.1K 0.01% 1372

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return